A rabbit monoclonal antibody against the antiviral and cancer genomic dna mutating enzyme apobec3b

35Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

The DNA cytosine deaminase APOBEC3B (A3B) is normally an antiviral factor in the innate immune response. However, A3B has been implicated in cancer mutagenesis, particularly in solid tumors of the bladder, breast, cervix, head/neck, and lung. Here, we report data on the generation and characterization of a rabbit monoclonal antibody (mAb) for human A3B. One mAb, 5210-87-13, demonstrates utility in multiple applications, including ELISA, immunoblot, immunofluorescence microscopy, and immunohistochemistry. In head-to-head tests with commercial reagents, 5210-87-13 was the only rabbit monoclonal suitable for detecting native A3B and for immunohistochemical quantification of A3B in tumor tissues. This novel mAb has the potential to enable a wide range of fundamental and clinical studies on A3B in human biology and disease.

Cite

CITATION STYLE

APA

Brown, W. L., Law, E. K., Argyris, P. P., Carpenter, M. A., Levin-Klein, R., Ranum, A. N., … Harris, R. S. (2019). A rabbit monoclonal antibody against the antiviral and cancer genomic dna mutating enzyme apobec3b. Antibodies, 8(3). https://doi.org/10.3390/ANTIB8030047

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free